Showing 1 - 7 results of 7 for search 'R. Kizlaitienė', query time: 0.02s Refine Results
  1. 1
    Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report

    Co-occurrence of Myasthenia Gravis and Multiple Sclerosis: A Case Report by G. Rynkevič, R. Kizlaitienė

    Published 2024-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?

    Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment? by A. Ovčinikova, R. Kizlaitienė

    Published 2019-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab

    The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab by I. Jonušaitė, N. Giedraitienė, G. Kaubrys, R. Kizlaitienė

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Relationship between circadian rhythm characteristics and chronotypes with multiple sclerosis: literature review

    Relationship between circadian rhythm characteristics and chronotypes with multiple sclerosis: literature review by Ieva Jonušaitė, Eglė Sakalauskaitė-Juodeikienė, Rūta Mameniškienė, R. Kizlaitienė

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The role of neurofilament light chain in the context of neurological disorders

    The role of neurofilament light chain in the context of neurological disorders by V. Taluntienė, R. Motiekaitytė, R. Kizlaitienė, N. Giedraitienė, G. Kaubrys

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic

    Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic by R. Kizlaitienė, N. Giedraitienė, I. Sereikė, J. Liutkienė, L. Leščinskienė, G. Kaubrys

    Published 2020-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists

    Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists by R. Kizlaitienė, D. Mickevičienė, L. Malcienė, N. Giedraitienė, R. Balnytė, D. Jatužis

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: